Table 1.
Summary of demographics, comorbidities, symptoms, and outcomes of patients admitted with SARS-CoV-2
| Demographics | |
|---|---|
| Age | 69 years (22-102) |
| Sex | 628 M / 403 F |
| Symptoms | |
|---|---|
| Dyspnoea | 797 (77.3%) |
| Cough | 444 (43%) |
| Ageusia | 50 (4.8%) |
| Anosmia | 66 (6.4%) |
| Chest pain | 96 (9.3%) |
| Headache | 46 (4.5%) |
| Fatigue | 228 (22%) |
| Arthralgia | 93 (9%) |
| Gastrointestinal symptoms | 94 (9%) |
| Fever (>37.5°) | 515 (50%) |
| Comorbidities | |
|---|---|
| Hypertension | 472 (45.7%) |
| Diabetes | 199 (19.3%) |
| Heart Disease (Previous myocardial infarction) | 746 (72.3%) |
| Heart Disease (Atrial fibrillation) | 226 (22%) |
| Heart Disease (Hearth failure) | 59 (5.7%) |
| COPD | 120 (11.6%) |
| Chronic lung failure | 17 (1.6%) |
| Cerebral vasculopathy | 86 (8.3%) |
| Cancer | 74 (7.2%) |
| Chronic renal insufficiency | 88 (8.5%) |
| Immunodeficiency | 19 (1.8%) |
| Obesity | 212 (20.5%) |
| Outcomes | |
|---|---|
| Deaths | 296 (28.7%) |
| Number of days prior to death | 14 ± 12.5 (mean ± STD) |
| Survived | 735 (71.3%) |
| Recovery days | 20 ± 14.3 (mean ± STD) |
| Intubated | 125 (12.2%) |
| Number of days intubated | 20.2 ± 15.2 (mean ± STD) |
| ICU |
144 (14%) 21 not intubated (15%) |
| Number of days spent in ICU | 21.2 ± 17.6 (mean ± STD) |
STD standard deviation, ICU intensive care unit, COPD chronic obstructive pulmonary disease